Cargando…
Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies
BACKGROUND: During febrile neutropenia in only 30 to 60 percent an infectious agent is identified. This diagnostic gap could hypothetically be reduced with the broad implementation of molecular detection techniques like PCR, which has revolutionized the detection of infectious diseases during the la...
Autores principales: | Jansen, Rogier R, Biemond, Bart J, Schinkel, Janke, Koekkoek, Sylvie M, Molenkamp, Richard, de Jong, Menno D, Visser, Caroline E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706282/ https://www.ncbi.nlm.nih.gov/pubmed/23805898 http://dx.doi.org/10.1186/1743-422X-10-212 |
Ejemplares similares
-
Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
por: Demirel, Aslıhan, et al.
Publicado: (2015) -
Development and evaluation of a four-tube real time multiplex PCR assay covering fourteen respiratory viruses, and comparison to its corresponding single target counterparts
por: Jansen, Rogier R., et al.
Publicado: (2011) -
Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity
por: Chong, Yong, et al.
Publicado: (2013) -
Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China
por: Yuan, Wei, et al.
Publicado: (2016) -
The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies
por: Çalık, Şebnem, et al.
Publicado: (2018)